Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
Braves and Reds engage in wild, high-scoring affair, with Braves clinching series victory in extra innings
US manufacturing activity contracts for the fifth straight month, with the ISM Manufacturing Index falling to a nine-month low, as weak demand, tariff pressures, and trade policy uncertainty weigh on the sector.
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
Braves and Reds engage in wild, high-scoring affair, with Braves clinching series victory in extra innings
US manufacturing activity contracts for the fifth straight month, with the ISM Manufacturing Index falling to a nine-month low, as weak demand, tariff pressures, and trade policy uncertainty weigh on the sector.
